PHIO PHARMACEUTICALS CORP.

PHIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A Nov 6, 2025
8-K Nov 6, 2025 FORM 8-K
8-K Nov 3, 2025 FORM 8-K
8-K Oct 31, 2025 FORM 8-K
4/A Sep 15, 2025
8-K Sep 15, 2025 FORM 8-K
4 Sep 15, 2025
4 Sep 15, 2025
4 Sep 15, 2025
4 Sep 15, 2025
4 Sep 15, 2025
4 Sep 15, 2025
4 Sep 15, 2025
S-8 Sep 11, 2025 REGISTRATION STATEMENT
8-K Sep 3, 2025 CURRENT REPORT
DEFA14A Aug 28, 2025 ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS
424B3 Aug 27, 2025 PROSPECTUS
EFFECT Aug 22, 2025
CORRESP Aug 21, 2025
UPLOAD Aug 21, 2025
S-3 Aug 15, 2025 REGISTRATION STATEMENT
10-Q Aug 14, 2025 FORM 10-Q FOR JUN 2025
8-K Aug 14, 2025 CURRENT REPORT
SCHEDULE 13G/A Aug 7, 2025
D Aug 4, 2025
← Newer Page 3 of 36 · 883 filings Older →